Table 1. Patient characteristics.
Variables | Patient number or median [range] |
---|---|
Recipient gender | |
Male | 6 |
Female | 9 |
Recipient age (years) | 58 [36–74] |
Donor gender | |
Male | 9 |
Female | 6 |
Donor age (years) | 40 [29–64] |
Graft type | |
Left | 5 |
Right | 10 |
Background liver disease | |
Viral | 7 |
Others | 8 |
MELD score | 17 [7–23] |
CTP score | 11 [10–13] |
Graft volume/standard liver volume (%) | 43.7 [31.2–67.1] |
Graft recipient weight ratio (%) | 0.79 [0.65–1.19] |
Simultaneous splenectomy at transplant | |
Yes | 12 |
No | 3 |
Intraoperative blood loss (mL) | 4,490 [875–18,450] |
Operation time (min) | 708 [509–978] |
Portal pressure at the end of the operation (mmHg) | 16 [13–21] |
Portal venous flow per gram of graft (mL/min/g) | 2.97 [1.53–7.42] |
Pretransplant M2BPGi (C.O.I.) | 9.75 [3.04–24.49] |
POD 1 M2BPGi (C.O.I.) | 1.48 [0.9–7.63] |
POD 3 M2BPGi (C.O.I.) | 1.47 [0.47–2.93] |
POD 7 M2BPGi (C.O.I.) | 1.49 [0.46–4.74] |
C.O.I., cutoff index; CTP, Child-Turcotte-Pugh; M2BPGi, Wisteria floribunda agglutinin positive human Mac-2 binding protein glycosylation isomer; MELD, Model for End-Stage Liver Disease; POD, postoperative days; SFSS, small-for-size syndrome